Press release
Global Preclinical Tomography System Market, Forecast to 2023
Preclinical Tomography System
Preclinical Tomography System is used tomography technology to the visualization of living animals for research purposes.
Scope of the Report:
- This report focuses on the Preclinical Tomography System in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
- The leading manufactures mainly are Bruker, SEDECAL, MR Solutions, Scanco Medical and PerkinElmer. Bruker is the largest manufacturer; its revenue of global market exceeds 69% in 2016. The next is EDECAL and MR Solutions.
Click the link below to read the Full copy of Preclinical Tomography System Market Report @ https://goo.gl/HKvdBf
There are three types product of preclinical tomography system market: CT, PET & SPECT and Composite System. CT accounts the largest proportion; however, Composite System will have faster growing rate.
Geographically, the global preclinical tomography system market has been segmented into North America, Europe, China, Asia (Ex China) and other. The North America held the largest consumption share in the global market, its revenue of global market exceeds 37% in 2016.
The next is Europe and China. China being the most populous country has fast growing preclinical tomography system market.
The worldwide market for Preclinical Tomography System is expected to grow at a CAGR of roughly 6.3% over the next five years, will reach 470 million US$ in 2023, from 320 million US$ in 2017.
Market Segment by Manufacturers, this report covers
- Bruker
- SEDECAL
- MR Solutions
- Scanco Medical
- PerkinElmer
- Mediso
- MILabs
- Trifoil Imaging
We are the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases. We provide over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
808, Real Tech Park, 8th Floor, Sector - 30A, Vashi
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Preclinical Tomography System Market, Forecast to 2023 here
News-ID: 1128875 • Views: …
More Releases for Preclinical
Driving Preclinical CRO Market Growth in 2025: The Role of Surging Demand For Pr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Preclinical CRO Market Size Growth Forecast: What to Expect by 2025?
In recent times, there has been a significant increase in the size of the preclinical CRO market. The market will develop from being worth $5.7 billion in 2024 to achieving a value of $6.26 billion the following year,…
DLL3 Inhibitors in Preclinical and Clinical Studies
Delta-Like Ligand 3 (DLL3) inhibitors have shown significant promise in preclinical and clinical studies, particularly for the treatment of aggressive cancers such as small cell lung cancer (SCLC) and neuroendocrine tumors. The selective expression of DLL3 in these malignancies makes it an attractive target for therapeutic intervention. This article explores the development and progress of DLL3 inhibitors in preclinical and clinical studies, highlighting their potential in modern oncology.
Download Report:
https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor
DLL3…
Preclinical CRO Market Size Forecast Between 2023-2032
The global market for Preclinical Contract Research Organizations (CROs) has witnessed substantial growth in recent years, driven by increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies. In 2022, the market size reached USD 5.2 Billion and is projected to grow to USD 10.7 Billion by 2032, with a compound annual growth rate (CAGR) of 7.6% from 2023 to 2032. This article delves into the current trends, drivers,…
Preclinical Imaging Market Opportunity | Size | Research Report
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- Preclinical Imaging Market was valued at USD 748.18 Million in 2023 and is projected to reach USD 1,109.10 Million by 2030, growing at a CAGR of 5.0% from 2024 to 2030.
The preclinical imaging market is being significantly driven by advancements in imaging modalities, such as MRI, PET, SPECT, CT, and optical imaging. These technologies provide researchers with non-invasive ways to visualize and study biological processes at the…
Preclinical Imaging Market - Transforming Research with Precision Imaging: Precl …
Newark, New Castle, USA: The "Preclinical Imaging Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Preclinical Imaging Market: https://www.growthplusreports.com/report/preclinical-imaging-market/7673
This latest report researches the industry structure, sales, revenue,…
Preclinical Imaging Market - Unlocking Clarity, Preserving Scientific Excellence …
Newark, New Castle, USA - new report, titled Preclinical Imaging Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Preclinical Imaging market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Preclinical Imaging market. The report offers an overview of the market, which…
